These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25957808)

  • 21. SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.
    Au-Yeung WT; Reinhall PG; Poole JE; Anderson J; Johnson G; Fletcher RD; Moore HJ; Mark DB; Lee KL; Bardy GH
    Heart Rhythm; 2015 Oct; 12(10):2058-66. PubMed ID: 26096609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary Prevention of Sudden Cardiac Death in Adults with Transposition of the Great Arteries: A Review of Implantable Cardioverter-Defibrillator Placement.
    Sodhi SS; Cedars AM
    Tex Heart Inst J; 2015 Aug; 42(4):309-18. PubMed ID: 26413012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk stratification and primary prevention of sudden cardiac death: sudden death prevention.
    Obias-Manno D; Wijetunga M
    AACN Clin Issues; 2004; 15(3):404-18. PubMed ID: 15475814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Implantable cardioverters-defibrillators: prevention of sudden death].
    Bokeriia LA; Revishvili ASh; Neminushiĭ NM
    Kardiologiia; 2009; 49(2):84-9. PubMed ID: 19254226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Non-pharmacologic prevention of sudden cardiac death].
    Jurkovicová O; Cagán S
    Bratisl Lek Listy; 1997; 98(7-8):423-39. PubMed ID: 9471337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improve the prevention of sudden cardiac arrest in emerging countries: the Improve SCA clinical study design.
    Zhang S; Singh B; Rodriguez DA; Chasnoits AR; Hussin A; Ching CK; Huang D; Liu YB; Cerkvenik J; Willey S; Kim YH
    Europace; 2015 Nov; 17(11):1720-6. PubMed ID: 26037794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shades of grey: the conundrum of implantable defibrillators in individuals with advanced CKD.
    Khattak A; Charytan DM
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1107-9. PubMed ID: 26111858
    [No Abstract]   [Full Text] [Related]  

  • 28. Family-based cardiac screening in relatives of victims of sudden arrhythmic death syndrome.
    McGorrian C; Constant O; Harper N; O'Donnell C; Codd M; Keelan E; Green A; O'Neill J; Galvin J; Mahon NG
    Europace; 2013 Jul; 15(7):1050-8. PubMed ID: 23382499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary prevention of sudden cardiac death with an entirely subcutaneous defibrillator in a patient with a large right atrial thrombus.
    Kolb C; Lennerz C; Semmler V; Jilek C
    Clin Res Cardiol; 2013 Feb; 102(2):169-70. PubMed ID: 23052334
    [No Abstract]   [Full Text] [Related]  

  • 30. Advances in the treatment of arrhythmias: implantable cardioverter-defibrillators.
    Groh WJ; Foreman LD; Zipes DP
    Am Fam Physician; 1998 Jan; 57(2):297-307, 310-2. PubMed ID: 9456993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evolution and revolution of the implantable cardioverter defibrillator.
    Indik JH
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):461-4. PubMed ID: 15225105
    [No Abstract]   [Full Text] [Related]  

  • 32. Evidence-based analysis of risk factors for sudden cardiac death.
    Goldberger JJ
    Heart Rhythm; 2009 Mar; 6(3 Suppl):S2-7. PubMed ID: 19251227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of sudden cardiac death.
    Israel CW
    Indian Heart J; 2014; 66 Suppl 1(Suppl 1):S10-7. PubMed ID: 24568819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The automatic implantable cardioverter-defibrillator: technology for preventing sudden cardiac death.
    Thakor NV; Natarajan A
    Med Des Mater; 1991 Mar; 1(3):16-24. PubMed ID: 10147992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Saving lives and reducing inappropriate device therapy: the MADIT family of implantable cardioverter-defibrillator and cardiac resynchronization therapy trials.
    Moss AJ
    Cardiol J; 2013; 20(3):217-9. PubMed ID: 23788293
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary prevention of sudden cardiac death: one step forwards and one step backwards.
    Cain ME
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3(3):115. PubMed ID: 16505838
    [No Abstract]   [Full Text] [Related]  

  • 37. Sudden cardiac death.
    Sra J
    Indian Heart J; 1999; 51(2):137-59. PubMed ID: 10407542
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
    Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epileptic patients who survived sudden cardiac death have increased risk of recurrent arrhythmias and death.
    Badheka A; Rathod A; Kizilbash MA; Lai Z; Mohamad T; Shah A; Afonso L; Jacob S
    J Cardiovasc Med (Hagerstown); 2010 Nov; 11(11):810-4. PubMed ID: 20543707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implantable cardioverter-defibrillator lead failure: how weak is the link?
    Brinker JA
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):758-9. PubMed ID: 18838965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.